Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
11.95
+0.14 (1.19%)
At close: Jan 29, 2026, 4:00 PM EST
11.99
+0.04 (0.33%)
After-hours: Jan 29, 2026, 5:31 PM EST

Omeros Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
202
Market Cap
847.26M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 201829.87M-34.96M-53.93%
Dec 31, 201764.83M23.21M55.77%
Dec 31, 201641.62M28.11M208.07%
Dec 31, 201513.51M12.97M2,406.31%
Dec 31, 2014539.00K-1.06M-66.31%
Dec 31, 20131.60M-4.42M-73.43%
Dec 31, 20126.02M1.50M33.11%
Dec 31, 20114.52M2.42M114.92%
Dec 31, 20102.11M661.00K45.78%
Dec 31, 20091.44M274.00K23.42%
Dec 31, 20081.17M-753.00K-39.16%
Dec 31, 20071.92M1.52M380.75%
Dec 31, 2006400.00K--
Dec 31, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Arvinas312.30M
Valneva SE211.09M
Geron183.40M
CytomX Therapeutics113.63M
Arbutus Biopharma14.61M
Janux Therapeutics10.00M
Prime Medicine5.98M
YD Bio510.36K
Revenue Rankings